Skip to content

Earnings call

Narayana Hrudayalaya Q3 FY26 earnings call: Narayana Hrudayalaya aspires to an 8.5% to 9% pre-IFRS margin

By . Assembled by software from the company's transcript. Not reviewed by a person.

Transcript filed .

The company aspires to an 8.5% to 9% pre-IFRS margin. The India business's margin expanded by almost 150-200 basis points on a YOY basis over the last two quarters, following transformation programs and payor mix optimization initiatives that led patients to opt for higher rate configuration while keeping volumes and occupancy intact. Private peers in the UK have anywhere from 30 to 50 / 60% of NHS work, whereas Practice Plus has almost 90% or more NHS work. The INR 3000 crore capex is to be funded by internal accruals and debt.

The numbers management gave

Results

  • The India business's margin expanded by almost 150-200 basis points on a YOY basis over the last two quarters, following transformation programs and payor mix optimization initiatives that led patients to opt for higher rate configuration while keeping volumes and occupancy intact.
    Show source
    The margin expansion that we saw in India business over the last two quarters, which is almost 150-200 basis points on YOY basis.

Money and capital

  • The INR 3000 crore capex is to be funded by internal accruals and debt.
    Show source
    The number is actually closer to INR 3000 crore, but the answer is still the same.
  • The company tracks net debt to EBITDA on a consol basis and endeavors to maintain the ratio below 2.5.
    Show source
    And our endeavor is to maintain a number below 2.5.
  • The company has taken GBP 150 million of debt and has a 2 + 5 years repayment schedule, over which it aspires to repay the debt.
    Show source
    We have taken debt GBP 150 million on this.
  • Equity for this was GBP 33 million.
    Show source
    Vinay Nadkarni: So, it is GBP 33 million equity and GBP 150 million debt, is it?
  • Capital will have a right of first refusal, so to say, for India, where it is deploying the bulk of its capital presently and over the next five years.
    Show source
    And as we've said several times before, the right of first refusal, so to say, for our capital will always be at home country in India, where we are most familiar and where we have the most opportunities to grow and where we are deploying the bulk of our capital presently and over the next five years as well.

What it expects ahead

What management expects

  • The company aspires to an 8.5% to 9% pre-IFRS margin.
    Show source
    We do aspire to be at that 8.5 to 9% pre-IFRS.
  • The company has hoped that the hospital would take about four quarters or one year to come out of its losses; it has been half that time.
    Show source
    To your question about how long it will take to come out of our losses, we've always hoped that such an operation would take about four quarters or one year.
  • The company is definitely not open to another international acquisition opportunity for the foreseeable future, as it has its hands full with its UK operation and Cayman activity.
    Show source
    Definitely not for the foreseeable future.
  • UK thesis was not counting on the NHS share reducing materially.
    Show source
    Our thesis wasn't counting on the NHS share reducing materially.
  • The company expects the UK acquisition's path to be flat or mildly positive and continues to hold that the acquisition will be EPS neutral for the group, despite this quarter being slightly distorted by a one-timer deal cost in the UK P&L.
    Show source
    So therefore, we do continue to hold our position that this acquisition will be EPS neutral for the group.
  • The company will start giving the same ambition post-IFRS next time onwards. Replaced by a later filing.
    Show source
    Next time onwards, we will start giving the same ambition post- IFRS.

What it is building and selling

Projects and capacity

  • The company plans to add a lot more oncology services in all the hospitals as minor investments.
    Show source
    We'll be adding a lot more oncology services in all the hospitals.

Demand and pricing

  • Private peers in the UK have anywhere from 30 to 50 / 60% of NHS work, whereas Practice Plus has almost 90% or more NHS work.
    Show source
    Anesh Shetty: Yeah, so private peers in the UK have anywhere from 30 to 50 / 60% of NHS work, whereas we are almost 90% or more NHS work.

Everything else said on the call

Group structure

  • The hospital has been fully operational under practice plus ownership for about a year, year and a half, and under NH for the past few months.
    Show source
    So, the hospital is fully operational.

People and governance

  • Doctor attrition at the senior level is high single digits.
    Show source
    But our doctor attrition at the senior level is high single digits.

What the company said on its earnings call, taken from its own transcript. Not advice.

Questions and answers

This transcript does not separate questions and answers, so they are not listed here.

Questions about this call

When was the Narayana Hrudayalaya Q3 FY26 earnings call transcript filed?
Narayana Hrudayalaya filed the transcript with the exchange on 24 Feb 2026. This page is built from that transcript.
What does this page list?
16 statements from the transcript across 7 topics, 7 of them with a figure. Each statement is shown with the transcript sentence it came from.
Are the analysts' questions included?
No. This transcript does not separate the questions from the answers, so they are not listed. The statements by topic still cover what management said.
Who wrote this page?
DalalOS Data Desk. Assembled by software from the company's transcript. Not reviewed by a person. How it is made, and what it leaves out, is on the method page linked from the byline.
Research and analysis only, not investment advice. Every statement on this page is the company's own, taken from its transcript; DalalOS adds no view on it and is not a SEBI-registered investment adviser. Something wrong? Report an error.
Narayana Hrudayalaya Q3 FY26 concall: Narayana Hrudayalaya aspires to an 8.5% to 9% pre-IFRS margin · DalalOS